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Elizabeth A. Cowles,1 Joy L. Kovar,2 Evan T. Curtis,1 Huihui Xu,1 and Shadi F. Othman1
Abstract
Millions of cases of bone injury or loss due to trauma, osteoporosis, and cancer occur in the United States each
year. Because bone is limited in its ability to regenerate, alternative therapy approaches are needed. Bone tissue
engineering has the potential to correct musculoskeletal disorders through the development of cell-based substi-
tutes for osteogenic tissue replacement. Multiple medical imaging techniques such as magnetic resonance micros-
copy (MRM) were investigated recently; these techniques are able to provide useful information on the
anatomical and structural changes of developing bone. However, there is a need for noninvasive approaches
to evaluate biochemical constituents and consequent compositional development associated with growing osteo-
genic constructs. In this study, near-infrared (NIR) optical imaging with a bone-specific NIR-targeted probe,
IRDye 800CW BoneTag (800CW BT), was applied in this study to longitudinally visualize regions of miner-
alization of tissue-engineered bone constructs in vivo. A fluorescent cell-based assay was performed to confirm
the preferential binding of 800CW BT to the mineralized matrix of differentiated osteogenically driven human
mesenchymal stem cells (hMSCs) in vitro. The hMSCs were seeded onto a biocompatible gelatin scaffold, allowed
to develop, and implanted into a mouse model. Engineered constructs were examined in vivo using NIR imaging
for bone mineralization, paired with MRM for verification of developing tissue. Results showed that NIR imaging
with 800CW BT labeling can effectively assess the calcification of the developing osteogenic constructs, which is
consistent with the analysis of excised tissue using NIR microscopy and histology. In conclusion, this study eval-
uated bone-like function of regenerating bone through tracking calcium deposition via NIR optical imaging with
a fluorophore-labeled probe in a noninvasive manner.
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Introduction
Millions of cases of bone injury or loss due totrauma, osteoporosis, and cancer occur in the United
States each year.1 Because bone is limited in its ability to re-
generate and remodel, natural healing is often insufficient.
Though allogeneic and autologous transplants are clinically
performed, their use is limited due to the risk of the infectious
and painful procedure.2 Therefore, an alternative strategy,
bone tissue engineering (TE)—which seeks to correct muscu-
loskeletal disorders through the development of cell-based
substitutes for osteogenic tissue replacement—is needed. TE
involves the use of progenitor cells, biocompatible scaffolds,
and duplication of differentiation and growth factors to
allow for cell growth and differentiation.3,4 For instance, mes-
enchymal stem cells (MSCs) can be stimulated to differentiate
into osteoblasts, chrondrocytes, or adipocytes, and can be
used as bone progenitor cells that, when seeded onto a
three-dimensional scaffold with appropriate stimulant, can
form osteocytic, chondrocytic, or adipocytic tissue.5,6
Imaging modalities has been used to understand the dy-
namic evolution of osteogenic engineered tissues both
in vitro and in vivo, but each modality has limitations. For ex-
ample, magnetic resonance microscopy (MRM) has been suc-
cessfully applied to assess the development and regeneration
of tissue-engineered bone;7,8 however, relatively low proton
density and short T2 relaxation times associated with bone tis-
sues often dampen signal intensities on the magnetic resonance
images in late stages of osteogenesis. X-ray microcomputed to-
mography of bone exhibits high resolution and contrast, but the
contrast is less apparent in the marrow and newly formed
bone;9 additionally the subjection of the tissue to ionizing radi-
ation causes undesired damage and harm.10 Finally, ultrasound
is noninvasive but has a relatively low spatial resolution,
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making it difficult to visualize the compositional and structural
changes in engineered bone constructs.11 Near-infrared (NIR)
optical imaging, on the other hand, with an appropriate fluoro-
phore-labeled probe has been used successfully for noninvasive
and longitudinal visualization of bone deposition in vivo.12
In particular, IRDye 800CW BoneTag (800CW BT), a
calcium-chelating tetracycline-derivative conjugated to the
NIR fluorophore IRDye 800CW, can bind to differentiated
mineralized osteoblast cultures and effectively target in vivo
native bone structures.12
In this article, we postulate that bone-like function of mes-
enchymally derived tissue-engineered bone constructs
implanted in a mouse model can be monitored through track-
ing calcium deposition via NIR optical imaging with a fluoro-
phore-labeled probe. To address this question, NIR optical
imaging with 800CW BT labeling was used to monitor the
process of osteogenesis through cell-based assays. The bind-
ing of the 800CW BT to mineral matrices of differentiated
osteogenic-like cells was confirmed by von Kossa histologi-
cal analysis. Once the preferential binding of 800CW BT
for differentiated MSCs was identified, osteogenic tissue-
engineered constructs were developed in vitro and implanted
into a mouse model. Over time, 800CW BT was injected and
visualized using NIR optical imaging in vivo. Finally, the
osteogenic constructs were excised and subjected to addi-
tional histologic and NIR microscopy measurements to estab-
lish specificity of binding.
Materials and Methods
Cell-based assays and histology of monolayer
Human MSCs (hMSCs) isolated from adult human bone
marrow were obtained commercially (PT-2501; Lonza,
Basel, Switzerland). The cells were incubated in MSC basal
medium (PT-3001 MSCGM Bullet Kit; Lonza) during
the expansion and growth process at 37C and 5% CO2. The
hMSCs were isolated by removing unattached cells during
media exchange; when hMSCs were *80% confluent, cells
were trypsinized and plated at a density of 3500 cells/mL
in 24-well plates for a total cell number of 7000 cells as de-
scribed previously.13 One day after plating, the cells intended
for osteogenic differentiation were stimulated using osteo-
genic induction medium (PT-3002 hMSC differentiation
BulletKit; Lonza) during the entire monolayer study,
while the undifferentiated cells (unstimulated control
group) were maintained in basal medium. The plates were
evaluated at two different time points: the undifferentiated
control group was evaluated at week 1, while the differenti-
ated group was evaluated at week 4, necessary for compara-
ble cell numbers between groups.
A fluorescent cell-based assay was used to evaluate bind-
ing efficiency of 800CW BT (LI-COR Biosciences, Lincoln,
NE) as a marker for differentiation of osteogenic cells. The
test was assessed in quadruplicate for the undifferentiated
and differentiated cells. The probe was prepared by reconsti-
tuting 10 nmol of 800CW BT in 0.5mL phosphate-buffered sa-
line (PBS) immediately prior to use. Undifferentiated and
differentiated cells were incubated for 1 h with 800CW BT
in concentrations of 200, 100, and 50 nM, diluted in osteogenic
media to measure the extent of mineralization. The cells were
fixed with 10% formalin for 20min and washed four times
with 1 · PBS + 0.05% Tween-20. The cells were blocked in
Odyssey Blocking Buffer (LI-COR) for 1.5 h and incubated
for 1 h with TO-PRO-3 (Invitrogen Corporation, Carlsbad,
CA) DNA stain (700 nm) diluted 1:5000. The cells were
again washed four times with 1 · PBS + 0.05% Tween-20. Flu-
orescence (excitation 774 nm, emission 805 nm) imaging data
for the 800CW BT were collected using an Odyssey CLx
Infrared Imaging System (LI-COR). The relative fluorescent
units (RFU) of undifferentiated and differentiated hMSCs
were determined by applying a radiometric analysis of fluo-
rescence (800-nm signal normalized to 700-nm signal). To in-
spect mineralization, the cells underwent von Kossa staining
using 5% silver nitrate (S8157; Sigma-Aldrich, St. Louis, MO)
after fixing in 10% formalin.14 Assessment of the stains was
conducted using a VWR VistaVision inverted microscope ret-
rofitted with a Microsoft LifeCam web camera for image ac-
quisition.
Tissue-engineered construct preparation and implantation
Osteogenic tissue-engineered constructs were prepared
using the hMSCs and a biodegradable sterile gelatin scaffold
(Gelfoam, Baxter Healthcare Corporation, Hayward, CA),
trimmed into 3.5mm · 3.5mm · 4mm sections and pre-
wetted for 24 h in MSCGM (Lonza). The hMSCs were
seeded onto the scaffold at a density of 106 cells/mL with
the help of slight vacuum generated by a 20-mL syringe.15
The scaffold-cell suspension was incubated at 37C and 5%
CO2 for 2 h before transfer to basic media for 24 h.
16 Differen-
tiation was induced the following day by culturing in osteo-
genic induction media. Following 4 weeks of in vitro
culture, the constructs were implanted in male nude immu-
nodeficient mice (nu/nuJ, Jackson Laboratories, Bar Harbor,
ME). All animals and procedures used in this study were
cared for and maintained under the supervision and guide-
lines of the University of Nebraska-Lincoln Institutional
Animal Care and Use Committee. For the implantation sur-
gery, the mice were anesthetized with 5% isoflurane. The
area was sterilized with an iodine scrub and solution before
implantation. The tissue-engineered construct was implanted
in the subcutaneous region 2 cm distal to the scapula on the
left side. An additional gelatin scaffold (cell-free construct)
was presoaked for 24 h in basic media and implanted in
the same location opposite the differentiated tissue con-
struct on the right side to serve as control. A nonfluorescing
silk suture (683G; Ethicon, Somerville, NJ) was used to close
the incision. After 7 days, the suture was removed and the
animals were monitored for 1 month using NIR optical
and MRM imaging.
Imaging of TE constructs
The 800CW BT was prepared as stated previously to the
concentration of 20 nmol/mL. All mice were anesthetized
with 2% isoflurane during the imaging sessions. One week
and 1 month after implantation, the mice were administered
a 2 nmol (100 lL) intraperitoneal injection of 800CW BT, the
recommended dose from previous studies.12 Images (dorsal,
left and right lateral views) were taken 24 h post-injection
using the Pearl Impulse Small Animal Imager (LI-COR).
Each image was acquired at a resolution of 85 lm. Following
NIR optical imaging, MRM studies were conducted in vivo
using a 9.4-T (400MHz for protons) 89-mm vertical bore scan-
ner (Agilent Technologies, Santa Clara, CA) equipped with a
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4-cm Millipede radiofrequency imaging probe and a 100 G/
cm maximum triple axis gradients. MRM images were ac-
quired using a fast spin-echo sequence with the following pa-
rameters: TR= 2000ms, TE = 9ms, field of view = 2.5 cm,
256 · 256 matrix, echo-train-length = 4 with 16 averages and
0.5-mm slice thickness.
Histology for osteoblast and calcium deposition
Following 1 month of in vivo regeneration, the mice were
euthanized and tissue was harvested, a portion of which
was sent to Histoserv Inc. (Germantown, MD) for hematoxylin
and eosin (H&E) staining, to label nuclei of cells in the con-
struct, and von Kossa staining, to identify area of mineraliza-
tion. Histologic slides were examined by a board-certified
pathologist for assessment of mineralization and calcium depo-
sition. Additionally, a portion was frozen for sectioning (5lm)
and imaged with fluorescent microscopy.
Results
Monolayer: cell-based assay and histology
The fluorescent cell-based assay was performed in order to
demonstrate the preferential binding of the 800CW BT to the
mineral matrix of differentiated osteogenic hMSCs. Figure 1a
shows the RFU of undifferentiated and differentiated hMSCs
incubated in increasing 800CW BT concentrations (0–
200 nM). The signal intensity for the differentiated osteogenic
cells was 4.45 to 7.75 times higher than in the undifferentiated
cells. To confirm mineralization, both groups were stained
with silver nitrate for von Kossa evaluation, which showed
black depositions when positive (Fig. 1b). Analysis of vari-
ance (ANOVA) confirmed a statistically significant difference
between undifferentiated and differentiated cells at 200 nM
800CW BT ( p < 0.05). ANOVA was performed using Graph-
Pad Prism software (La Jolla, CA) to assess significance be-
tween treatment groups.
In vivo implantation and ex vivo analysis
The mice were imaged using NIR optical imaging at two
time points. Figure 2 shows the white light (grayscale) and
800-nm fluorescent images (green) of a mouse at 1 week
(Fig. 2a, b) and 1 month (Fig. 2c, d) post implantation. The
control scaffold was apparent in the white light image at 1
week (Fig. 2a), while it could not be identified in the
1-month image (Fig. 2c). Additionally, the control scaffold
did not show any fluorescence. The construct in the fluores-
cence image at 1 week contained a higher signal intensity
compared with the surrounding tissue (Fig. 2b). The construct
continued to regenerate for 1 month and exhibited a 4.5-fold
increase in signal intensity and a 3.3-fold increase in area of
regenerating tissue (Fig. 2d).
Figure 2e shows the results of MRM following NIR optical
imaging at 1 month. MR signal intensity was reduced for the
construct when compared with adjacent tissues. Figure 2f
shows an area of black deposition on a von Kossa–prepared
slide. The same slide was imaged using NIR microscopy at
800 nm, and Figure 2g shows fluorescence corresponding to
the areas of mineralization. Figure 2h shows a portion of
the excised tissue stained by H&E. From the histological anal-
ysis, the construct was determined to be highly calcified and
appeared as bone.
Discussion
Previously, in vitro mineralization for bone-forming cells
such as osteoblasts was quantified using a calcein bound to
hydroxyapatite, a good biological marker for osteoblast activ-
ity, using a fluorescence multiwell plate reader at 530-nm
emission.17
Native bone tissue formation and remodeling in vivo have
been shown to be successfully assessed through the use of
calcium-binding fluorescent dyes, which bind areas of miner-
alization and fluoresce in the NIR region of the spectrum.12
FIG. 1. Near-infrared (NIR) cell-based assay performed on the humanmesenchymal stem cells (hMSC) monolayer to confirm
the preferential binding of the IRDye 800CW BoneTag (800CW BT) to developed osteogenic cells. (a) Confluent cultures of
undifferentiated and differentiated hMSCs were incubated in increasing 800CW BT concentrations (0–200 nM). Relative fluo-
rescent units (RFU) data are plotted as means with standard deviations. Analysis of variance (ANOVA) showed a statistically
significant difference between undifferentiated and differentiated cells at the 200 nM concentration ( p < 0.05). (b) von Kossa
staining of hMSC monolayer, microscopically imaged at 250· magnification.
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They have been shown to effectively label native skeletal fea-
tures and bone mineralization remodeling processes, as well
as preferentially bind mineral matrices of osteogenic differen-
tiated MC3T3-E1 cells in culture. In vivo imaging in the NIR
spectrum (650–900 nm) provides high sensitivity and signal-
to-noise ratios compared with imaging at the visible wave-
lengths due to the reduced light absorption and scattering
of NIR waves in biological tissues.18
Based on these findings, the use of 800CW BT was exam-
ined for effectively binding and labeling mesenchymally de-
rived osteogenic constructs. In the cell-based assay, the
results demonstrated the preferential binding of 800CW BT
to the mineral matrix produced after differentiation. The sig-
nal intensity levels of the assay increased with increasing
800CW BT concentrations, indicating the cells did not reach
a saturation level in the range of 0–200 nM; therefore, an op-
timal dose cannot be stated and should be investigated in fu-
ture studies. Similar findings were observed previously with
increasing concentrations of hydroxyapatite when studying
calcein binding in osteoblast cells.17 GLP toxicity data on
IRDye 800CW and GMP quality dye are available, and a
drug master file is on record with both U.S. and European
regulatory agencies, which facilitates clinical translation.19
The 800CW BT successfully bound regions of mineraliza-
tion in osteogenic construct but did not bind to the control
scaffold. In addition, the control scaffold exhibited no auto-
fluorescence at 800 nm. Since the construct was labeled at
two time points, with greater signal intensity and signal
area at the 1-month post-implantation compared with the
1-week time point, the results indicated a potential for peri-
odically monitoring regenerating tissue-engineered osteo-
genic construct mineralization and remodeling processes.
The 800CW BT persists in bone for an extended time period
but progressively clears in a few weeks. A longitudinal
study with a longer duration, as well as the use of a larger
statistical sample size would assist in further promoting
the benefit of this novel technology. MRM was used to indi-
cate the location and size of the construct in relation to the
NIR image prior to excising the tissue and performing histo-
logical analysis; the decreased signal intensity of the con-
struct in the MR image indicated a relatively low number
of hydrogen atoms and short T2 relaxation time, which are
typical traits of bone tissue as described previously.20,21
After in vivo imaging, the construct was excised and under-
went NIR microscopy to visualize binding of the 800CW BT
to bone mineralization established with H&E and von Kossa
FIG. 2. Optical imaging of implanted osteogenic constructs (circled in red) in a mouse with corresponding histologic analysis
confirming mineralization. The mice were injected 1 week (a, b) and 1 month (c, d) post-implantation with 800CW BT and
evaluated 24 h later with NIR optical imaging. White light images (a, c) indicate location of differentiated and control implan-
tation sites. NIR images taken at the same time points (b, d) indicate binding and labeling of osteogenic tissue constructs with
800CW BT reflected in higher signal intensities for these regions compared to the surrounding tissue. Following optical imag-
ing, magnetic resonance microscopy (MRM) of the osteogenic constructs confirmed the presence of the tissue (e). Following
in vivo imaging, the osteogenic construct was excised and cut in 5-lm sections for microscopy of adjacent von Kossa (f)
and NIR microscopy (g). Additional histological analysis included hematoxylin and eosin staining of slides at 40· magnifi-
cation (h).
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staining. However, von Kossa staining alone was reported
to be insufficient to confirm that mineralization in vitro rep-
resents bone formation,22 and our mineralization results
were confirmed with H&E and von Kossa staining by a cer-
tified pathologist as well as NIR microscopy. With the suc-
cessful preliminary results we have shown in this study, it
would be prudent to include further matrix component
characteristics in future work.
Although successful in longitudinal and noninvasive stud-
ies following osteogenesis, NIR optical imaging does exhibit
limitations as an imaging modality. NIR is a planar imaging
technology and proper orientation is needed or images will
suffer from low penetration depth, especially as compared
to modalities such as volumetric MRM. Figure 3 shows NIR
images of the dorsal and left planes of an implanted con-
struct. The dorsal view cannot fully visualize the entire con-
struct due to low penetration depth (Fig. 3a), while the left
view provides a complete image representation of the con-
struct (Fig. 3b). Subcutaneous implants are easily visualized
by NIR planar imaging though NIR tomography would
give a more three-dimensional rendering similar to MRM.23
MRM does not suffer from penetration depth limitation but
lacks NIR specificity (Fig. 3c). In this specific subject, the con-
struct was fragmented, unintentionally, into three pieces dur-
ing surgery, which highlights the better specificity of optical
imaging (identified the three pieces in the left view) com-
pared with low signal intensity MRM image smeared with
susceptibility artifact. Multimodal imaging has the potential
to overcome the problems of individual imaging modalities
by providing more comprehensive images of engineered con-
struct evolution to fully examine the composition, structure,
and function noninvasively.
Future applications of NIR probes in labeling of tissue-
engineered osteogenic constructs should include examining
the effect of advanced scaffolding technique such as bio-
printed scaffolds.24 In addition, NIR imaging may be used
to monitor the produced mineral matrix under various fac-
tors, for example, vascular endothelial growth factor, which
promotes vascularization,25 or implantation of an osteogenic
construct in a native bone location.26 Additionally, future use
of various NIR probes that fluoresce at different wavelengths
could potentially allow for imaging of incremental increases
in mineralization, which would lead to a better understand-
ing of bone growth and remodeling mechanisms.12 The na-
ture of the high signal intensity obtained from 800CW BT to
the desired target molecules provides a distinct advantage
over the low-level signal of MRM in bone or the harmful ion-
izing radiation of X-ray and computed tomography. In con-
clusion, the presence of bone-like mineral deposition was
evaluated noninvasively in osteogenic tissue-engineered con-
structs through tracking calcium deposition via NIR with a
fluorophore-labeled probe.
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